Otsuka Pharmaceutical Europe and Lundbeck have announced that the European Commission has approved Rxulti (brexpiprazole) for ...
Grifols has announced positive results from its phase 2/3 clinical trial evaluating the efficacy and safety of intravenous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback